- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4747 - QuinolinesIsoquinolines spiro-condensed
Patent holdings for IPC class A61K 31/4747
Total number of patents in this class: 152
10-year publication summary
|
9
|
16
|
4
|
12
|
5
|
9
|
12
|
10
|
16
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10262 |
13 |
| F. Hoffmann-La Roche AG | 7837 |
4 |
| Merck Sharp & Dohme Corp. | 2183 |
4 |
| Astellas Pharma Inc. | 1044 |
4 |
| The Broad Institute, Inc. | 1977 |
4 |
| Pfizer Inc. | 3386 |
3 |
| The General Hospital Corporation | 4870 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2664 |
3 |
| Yale University | 2533 |
3 |
| Ascentawits Pharmaceuticals, Ltd. | 78 |
3 |
| Bristol-myers Squibb Company | 4742 |
2 |
| Genentech, Inc. | 4104 |
2 |
| Janssen Pharmaceutica N.V. | 3168 |
2 |
| Aptinyx Inc. | 19 |
2 |
| Asahi Kasei Pharma Corporation | 115 |
2 |
| Cancer Research Technology Limited | 514 |
2 |
| Ligand Pharmaceuticals Incorporated | 167 |
2 |
| Pain Therapeutics, Inc. | 38 |
2 |
| Raqualia Pharma Inc. | 123 |
2 |
| Schering Corporation | 350 |
2 |
| Other owners | 88 |